In particular, we identified three new genes (ECM1, ATF5, and EOMES) with potential anti-cancer functions that may promote the understanding of the molecular mechanisms of HCC development and progression and potentiate the future clinical applications of 5hmC detection. This evidence concerns the gene ATF5 and cancer.